Emosis Overview
- Year Founded
-
2014
- Status
-
Out of Business
- Employees
-
15
- Latest Deal Type
-
Liquidation
Emosis General Information
Description
Operator of a medical technology company intended for cardiovascular and cerebrovascular diseases. The company specializes in the development and commercialization of in vitro diagnostic tests for hemostasis abnormalities that cause hemorrhagic or thromboembolic manifestations, enabling patients to get neurovascular diseases, cancer, pregnancy, and pharmacological and non-pharmacological therapy management.
Contact Information
Website
www.emosis-diagnostics.comCorporate Office
- 11 rue de l'Industrie
- 67400 Illkirch-Graffenstaden
- France
Corporate Office
- 11 rue de l'Industrie
- 67400 Illkirch-Graffenstaden
- France
Emosis Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Bankruptcy: Liquidation | 06-Jun-2023 | Completed | Bankruptcy: Liquidation | |||
| 8. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 7. Later Stage VC | 29-Sep-2022 | Completed | Generating Revenue | |||
| 6. Later Stage VC | 12-May-2020 | Completed | Generating Revenue | |||
| 5. Later Stage VC | 02-Jul-2019 | Completed | Generating Revenue | |||
| 4. Early Stage VC | 26-Jun-2018 | Completed | Generating Revenue | |||
| 3. Grant | 01-Apr-2017 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 15-Mar-2016 | $1.1M | $1.1M | Completed | Generating Revenue | |
| 1. Accelerator/Incubator | 01-Jan-2014 | Completed | Startup |
Emosis Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Preference | ||||||||
| Preference |
Emosis Patents
Emosis Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2018242607-A1 | A rapid, on-demand heparin-induced thrombocytopenia functional assay | Inactive | 29-Mar-2017 | ||
| CA-3057743-A1 | A rapid, on-demand heparin-induced thrombocytopenia functional assay | Pending | 29-Mar-2017 | ||
| EP-3602070-A1 | A rapid, on-demand heparin-induced thrombocytopenia functional assay | Active | 29-Mar-2017 | ||
| EP-3602070-B1 | A rapid, on-demand heparin-induced thrombocytopenia functional assay | Active | 29-Mar-2017 | ||
| ES-2924187-T3 | A rapid, on-demand heparin-induced thrombocytopenia functional assay | Active | 29-Mar-2017 | G01N33/6893 |
Emosis Signals
Emosis FAQs
-
When was Emosis founded?
Emosis was founded in 2014.
-
Where is Emosis headquartered?
Emosis is headquartered in Illkirch-Graffenstaden, France.
-
What is the size of Emosis?
Emosis has 15 total employees.
-
What industry is Emosis in?
Emosis’s primary industry is Diagnostic Equipment.
-
Is Emosis a private or public company?
Emosis is a Private company.
-
What is Emosis’s current revenue?
The current revenue for Emosis is .
-
How much funding has Emosis raised over time?
Emosis has raised $4.51M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process